ClinConnect ClinConnect Logo
Search / Trial NCT06931730

Reprogramming Energy Homeostasis in Overweight Individuals Via Exercise, Cognitive, and Social Training

Launched by BAMBINO GESÙ HOSPITAL AND RESEARCH INSTITUTE · Apr 9, 2025

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Childhood Obesity Cognitive Training Social Training Environmental Enrichment Leptin Lifestyle Modification Overweight Obesity Energy Expenditure Thermogenesis Physical Activity Leptin Sensitivity Leptin Resistance

ClinConnect Summary

The RESILIENT project is a clinical trial aimed at understanding how to improve the body's response to a hormone called leptin in individuals who are overweight or obese, including both children and adults. Leptin helps control hunger and energy balance, but some people can become resistant to its effects. This study will explore whether combining Cognitive Training (which focuses on thinking skills) and Social Training (which emphasizes social interactions) can enhance leptin sensitivity more effectively than a standard health behavior program that includes diet and exercise. Participants will be involved in an 8-week program followed by a 12-week period without interventions.

To join the study, individuals must be aged between 21 and 40, have a condition of overweight or obesity, and have a minimum IQ of 85. Those with certain types of genetic obesity, mobility issues, systemic diseases, or who are currently on medication for chronic conditions will not be eligible. Throughout the trial, participants will undergo various assessments to measure how effective these interventions are, which may help lead to better long-term treatments for obesity and its related challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • a condition of overweight or obesity
  • Intelligence Quotient (IQ) ≥ 85
  • Exclusion Criteria:
  • genetic or syndromic obesity;
  • reduced mobility;
  • systemic diseases;
  • ongoing pharmacological treatment for chronic conditions.

About Bambino Gesù Hospital And Research Institute

Bambino Gesù Hospital and Research Institute, located in Rome, Italy, is a leading pediatric healthcare facility renowned for its commitment to advancing child health through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institute focuses on developing cutting-edge therapies and interventions for various pediatric conditions, underpinned by a multidisciplinary approach that integrates clinical practice, research, and education. With a strong emphasis on patient-centered care, Bambino Gesù fosters collaboration with international research networks and regulatory bodies to ensure the highest standards of safety and efficacy in its trials, ultimately striving to improve health outcomes for children globally.

Locations

Rome, , Italy

Rome, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported